# 4e Therapeutics, Inc. — Form D

4e Therapeutics, Inc. of AUSTIN, TX, a company, filed a Form D exempt-offering notice with the SEC on 2021-11-12. The offering totals $2.0M, of which $1.9M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2021-11-12
- Form: D
- Accession: 0001888582-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $1.9M
- Remaining: $105K
- Investors: 23
- Date of first sale: 2021-10-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-420829

## Issuer

- Name: 4e Therapeutics, Inc.
- CIK: 0001888582
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 3800 N. LAMAR BLVD, AUSTIN, TX, 78756
- Phone: 512-577-7779

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Thomas Craig Benson | Director | Austin, TX |
| Eric Craig Price | Director | Austin, TX |
| Joseph Craig Price | Director | Austin, TX |
| Theodore Craig Price | Director | Austin, TX |
| Thomas Craig Benson | Executive Officer | Austin, TX |

## More

- [CIK 1888582 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1888582&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001888582-21-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.